Three-Dimensional Trunk and Lower Limbs Characteristics during Gait in Patients with Huntington's Disease

Frontiers in Neuroscience
Elzbieta MirekAndrzej Szczudlik

Abstract

Objective: A number of studies on gait disturbances have been conducted, however, no clear pattern of gait disorders was described. The aim of the study was to characterize the gait pattern in HD patients by conducting analysis of mean angular movement changes the lower limb joints and trunk (kinematics parameters). Methods: The study group consisted of 30 patients with HD (17 women and 13 men). The reference data include the results of 30 healthy subjects (17 women and 13 men). Registration of gait with the Vicon 250 system was performed using passive markers attached to specific anthropometric points directly on the skin, based on the Golem biomechanical model (Oxford Metrics Ltd.). The research group and the control group were tested once. Results: Statistically significant (p < 0.05) angular changes in gait cycle for HD patients were observed in: insufficient plantar flexion during Loading Response and Pre-swing phases; insufficient flexion of the knee joint during Initial Swing and Mid Swing phases; excessive flexion of the hip in Terminal Stance and Pre-swing phases and over-normative forward inclination of the trunk in all gait phases. It should be noted that the group of patients with HD obtained, for all the mean angul...Continue Reading

References

Jan 1, 1979·Neurology·I Shoulson, S Fahn
Jun 1, 1992·Neurology·J TianS E Folstein
Oct 1, 1985·Neurology·W C Koller, J Trimble
Mar 1, 1996·Movement Disorders : Official Journal of the Movement Disorder Society
Jan 23, 1999·Archives of Physical Medicine and Rehabilitation·N C ReynoldsB M Myklebust
Mar 20, 2001·Journal of the International Neuropsychological Society : JINS·J SnowdenD Neary
Sep 25, 2004·Movement Disorders : Official Journal of the Movement Disorder Society·Belinda BilneyNellie Georgiou-Karistianis
Apr 3, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·Yvette A M GrimbergenMarten Munneke
Apr 17, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·Ashwini K RaoKaren S Marder
Jul 21, 2009·Revue neurologique·C MoreauJ-P Azulay
Oct 1, 2014·BMC Neurology·Mary Danoudis, Robert Iansek
Jan 1, 2003·Journal of the Japanese Physical Therapy Association = Rigaku Ryōhō·Hitoshi TsushimaJennifer McGinley

❮ Previous
Next ❯

Citations

Feb 13, 2020·Journal of Neurology·Heiko GaßnerZacharias Kohl
Feb 13, 2019·Movement Disorders Clinical Practice·Pichet Termsarasab, Steven J Frucht
Jan 20, 2021·Medical Engineering & Physics·Y CelikA Godfrey
Jun 16, 2021·Artificial Intelligence in Medicine·Alexandra-Maria TăuţanEmiliano Santarnecchi

❮ Previous
Next ❯

Methods Mentioned

BETA
pharmacotherapy
itself

Software Mentioned

STATISTICA
Vicon

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.